Rotterdam, October 25, 2007 - The Erasmus MC Biomedical Fund announced today the incorporation and the closure of the seed financing round of Cavadis B.V.
Cavadis is a spin-off company from the University Medical Center Utrecht (department of experimental cardiology) and the Erasmus University Medical Center in Rotterdam (department of bioinformatics). Cavadis’ goal is to deliver diagnostic and therapeutic tools for the treatment of patients who are prone to develop unstable coronary syndromes due to the presence of vulnerable plaques.
For any information, please contact:
Harm de Vries hdevries@erasmusmcfund.nl 06-53216339
